EUVIMEDEUVIMED entdecken
Crossref

Factors Associated with Delayed Thrombolytic Medication among Patients with ST-Segment Elevation Myocardial Infarction in Southern Thailand

Mamaphoasee Suemae, Bhunyabhadh Chaimay, Somkiattiyos Woradet

Journal of Health Research · 13.03.2025 · 39 (1)

DOI: 10.56808/2586-940x.1121 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Health Research, online erschienen am 13.03.2025. Verfasst von Mamaphoasee Suemae und 2 weiteren Autor:innen. Die Arbeit nennt 36 Literaturangaben.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

ST-Segment Elevation Myocardial Infarction (STEMI) is among the most prevalent heart diseases worldwide and a leading cause of death. Delayed thrombolytic treatment significantly increases mortality risk in affected patients. This study aimed to identify factors associated with delayed administration of thrombolytic medication in STEMI patients.

Methods

A cross-sectional analytical study was conducted in Narathiwat Province, involving 1,074 STEMI patients documented in the Acute Coronary Syndrome Registry between January 1, 2016, and December 31, 2021. Of these, 781 eligible patients were categorized into two groups: 464 with delayed thrombolytic medication and 317 without. Descriptive statistics and multiple logistic regression used for data analysis.

Results

The proportion of patients experiencing delayed thrombolytic medication was 59.4% (95% CI: 55.8-62.9). Factors such as the total number of underlying diseases, Killip classification, and timing of accessing health services were associated with delayed thrombolytic medication. Patients with four underlying diseases had a reduced risk of delayed thrombolytic medication (AOR = 0.40, 95% CI: 0.24-0.63). Conversely, those diagnosed with cardiogenic shock (Class IV) (AOR = 3.74, 95% CI: 1.94-7.20) and those accessing services at night increased risk of delayed thrombolytic mediation (AOR = 2.16, 95% CI: 1.37-3.40).

Conclusion

The number of underlying diseases, Killip classification, and timing of health service access were linked to delayed thrombolytic medication. STEMI patients with advanced Killip classification, particularly those seeking care at night, should receive intensified attention to ensure timely administration of thrombolytic, thereby mitigating disease progression and reducing mortality. Keywords: Delayed Thrombolytic Medication, ST-elevation myocardial infarction, Thrombolytic therapy, Thailand

Zitieren

APA

Suemae, M., Chaimay, B., & Woradet, S. (2025). Factors Associated with Delayed Thrombolytic Medication among Patients with ST-Segment Elevation Myocardial Infarction in Southern Thailand. Journal of Health Research, 39(1). https://doi.org/10.56808/2586-940x.1121

Vancouver

Suemae M, Chaimay B, Woradet S. Factors Associated with Delayed Thrombolytic Medication among Patients with ST-Segment Elevation Myocardial Infarction in Southern Thailand. Journal of Health Research. 2025;39(1). doi:10.56808/2586-940x.1121

BibTeX
@article{Suemae2025,
  author = {Suemae, Mamaphoasee and Chaimay, Bhunyabhadh and Woradet, Somkiattiyos},
  title = {Factors Associated with Delayed Thrombolytic Medication among Patients with ST-Segment Elevation Myocardial Infarction in Southern Thailand},
  journal = {Journal of Health Research},
  year = {2025},
  volume = {39},
  number = {1},
  doi = {10.56808/2586-940x.1121}
}
Kostenlos starten →